Icosagen

Overview

Icosagen is an end-to-end Contract Research, Development & Manufacturing Organization (CRDMO) that bridges CRO and CDMO capabilities under one roof. The company specializes in antibody and protein biologics solutions, supporting clients across the full lifecycle from early discovery through GMP manufacturing.

Core Service Areas

Antibody Discovery & Development

• Early antibody developability assessment
• Antibody discovery (phage display, B-cell panning, hybridoma sequencing, immunization)
• Antibody development and engineering (bispecific antibody engineering, affinity maturation, humanization)
• Antibody-drug conjugate (ADC) development and manufacturing

Protein Production

• Transient expression systems
• Bispecific antibodies
• Membrane protein expression
• ADCC enhancement
• Protein purification and analytics

Cell Line Development

• Cell line development services
• Cell-based assays

Process Development & Manufacturing

• Upstream process development
• Downstream process development
• GMP manufacturing capabilities
• Food microbiology testing

Proprietary Technologies

Icosagen operates proprietary platforms including HybriFree Technology, QMCF Technology, and IcoCell® Technology to support client programs.

Client Base

The company has partnered with numerous biotech and pharma organizations globally, with demonstrated expertise in supporting pre-clinical antibody/protein production, characterization, and lead optimization phases. Client testimonials highlight technical expertise in complex protein expression, reliability, quick turnaround times, and transparent communication.